Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

223 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
Gales AC, Jones RN, Sader HS. Gales AC, et al. Clin Microbiol Infect. 2006 Apr;12(4):315-21. doi: 10.1111/j.1469-0691.2005.01351.x. Clin Microbiol Infect. 2006. PMID: 16524407
[Evaluation of in vitro activity of new fluoroquinolones, cephalosporins and carbapenems against 569 gram-negative bacteria].
Gales AC, Pignatari AC, Jones RN, Baretta M, Sader HS. Gales AC, et al. Rev Assoc Med Bras (1992). 1997 Apr-Jun;43(2):137-44. doi: 10.1590/s0104-42301997000200010. Rev Assoc Med Bras (1992). 1997. PMID: 9336049 Portuguese.
Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group.
Sader HS, Jones RN, Gales AC, Winokur P, Kugler KC, Pfaller MA, Doern GV. Sader HS, et al. Diagn Microbiol Infect Dis. 1998 Dec;32(4):289-301. doi: 10.1016/s0732-8893(98)00124-2. Diagn Microbiol Infect Dis. 1998. PMID: 9934546 Clinical Trial.
Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
Yamaguchi K, Mathai D, Biedenbach DJ, Lewis MT, Gales AC, Jones RN. Yamaguchi K, et al. Diagn Microbiol Infect Dis. 1999 Jun;34(2):123-34. doi: 10.1016/s0732-8893(99)00019-x. Diagn Microbiol Infect Dis. 1999. PMID: 10354863 Clinical Trial.
Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.
Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, Sader HS, Kugler K, Beach M. Diekema DJ, et al. Clin Infect Dis. 1999 Sep;29(3):595-607. doi: 10.1086/598640. Clin Infect Dis. 1999. PMID: 10530454
Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
Gales AC, Jones RN, Gordon KA, Sader HS, Wilke WW, Beach ML, Pfaller MA, Doern GV. Gales AC, et al. J Antimicrob Chemother. 2000 Mar;45(3):295-303. doi: 10.1093/jac/45.3.295. J Antimicrob Chemother. 2000. PMID: 10702547
Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study Group.
Gales AC, Jones RN, Pfaller MA, Gordon KA, Sader HS. Gales AC, et al. Int J Infect Dis. 2000;4(2):75-84. doi: 10.1016/s1201-9712(00)90098-5. Int J Infect Dis. 2000. PMID: 10737843 Clinical Trial.
Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America.
Gales AC, Gordon KA, Wilke WW, Pfaller MA, Jones RN. Gales AC, et al. Diagn Microbiol Infect Dis. 2000 Jan;36(1):61-4. doi: 10.1016/s0732-8893(99)00121-2. Diagn Microbiol Infect Dis. 2000. PMID: 10744370
223 results
Jump to page
Feedback